China, Dec. 18 /PRNewswire/ -- Packard BioScience Company (Nasdaq: PBSC - news) and BioLinks Informatics, Inc. announced today an agreement in which BioLinks will purchase a large number of ScanArray® microarray analysis systems from Packard's wholly-owned subsidiary Packard BioChip Technologies, LLC. The agreement marks one of the first major commercialization efforts of microarrays in the diagnostics field in China.
BioLinks intends to package its market leading biochips and bioinformatics software with the Packard ScanArray microarray analyzers to offer a turn-key solution to genomics researchers in the Pacific Rim. Shipments are scheduled to begin this week and should continue through April 2001.
``Presently, our ScanArray system is the market leading microarray scanner in China,'' said Yuk Lam Lo, Ph.D., president of Packard's Pacific office in Hong Kong. ``It's a win-win situation to couple our systems with the bioinformatics software and content chips of a pioneer in diagnostics in the Chinese market. It will strengthen our market presence, and it will give customers an opportunity to purchase the best technologies on the market today from one source.''
BioLinks Informatics Inc., Shanghai is a pioneer in the Chinese market building a bioinformatics circulation system throughout China. ChinaGeneNet is the largest e-commerce platform for life science products and bioinformatics, and is the premier gateway for life science researchers in China. BioWindow Gene Development Inc., the sister company of BioLinks Informatics, is a leading genomics company in China engaged in large-scale gene cloning, gene sequencing, gene function research, bioinformatics, microarray, and drug discovery. BioWindow provides full-length gene database service and patented gene products to pharmaceutical and biotechnology industries all over the world, and assists researchers in every step of drug discovery and development.
Packard BioChip Technologies' Instruments Division manufactures the ScanArray® system with confocal laser scanning technology for gene expression, mapping, high-throughput screening, drug discovery and other microarray applications.... |
